Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases.
Chen C, Zhou Y, Ning X, Li S, Xue D, Wei C, Zhu Z, Sheng L, Lu B, Li Y, Ye X, Fu Y, Bai C, Cai W, Ding Y, Lin S, Yan G, Huang Y, Yin W.
Chen C, et al.
J Neuroinflammation. 2022 Dec 28;19(1):315. doi: 10.1186/s12974-022-02682-w.
J Neuroinflammation. 2022.
PMID: 36577999
Free PMC article.